M. D. Anderson launches graduate program in cancer metastasis

March 26, 2009

HOUSTON - A one-of-a-kind graduate program that focuses on the most lethal aspect of cancer will open this fall at The University of Texas M. D. Anderson Cancer Center with support from a highly competitive grant from The University of Texas System.

The Graduate Program in Cancer Metastasis Research: Bench to Bedside, will concentrate on understanding and attacking the spread of cancer from its original site to other organs. The program will be offered through The University of Texas Graduate School of Biomedical Sciences at Houston, a combined program of M. D. Anderson and The University of Texas Health Science Center at Houston.

"Metastasis is far and away the major killer of cancer patients, and this doctoral program is the first to treat the study of metastasis as a separate discipline," said program organizer Gary E. Gallick, Ph.D., professor and director of education in M. D. Anderson's Department of Genitourinary Medical Oncology and a member of the GSBS faculty.

UT System allocated $485,250 to the metastasis program over three years, one of only seven grants awarded in a systemwide competition called the Graduate Program Initiative. The University of Texas System Board of Regents allocated $5 million for the initiative to cultivate innovative programs that will attract high-quality graduate students to UT System institutions. Each institution submitted multiple proposals.

"It's crucial that we improve our basic understanding of the underlying mechanisms for the spread of cancer to distant sites," said M. D. Anderson Provost and Executive Vice President Raymond DuBois, M.D. Ph.D. "This program will enhance the training of future scientists who will advance metastasis research."

The metastasis program integrates a traditional hypothesis-driven, basic-science research approach with M. D. Anderson's strong emphasis on cultivating close collaborations among physicians and scientists. "Students will learn to appreciate the clinical aspects of metastasis by visiting clinics and hearing physicians' perspectives on how the basic science issues worked on by students play out in the clinic," Gallick said.

Many institutions have established interdisciplinary research programs in cancer biology that include metastasis research. The organizers of the M. D. Anderson cancer metastasis program have tailored new courses and approaches to address unique requirements of metastasis research, providing students an unparalleled educational opportunity. The only similar program is offered jointly by the Université de Lausanne in Switzerland in conjunction with the Ludwig Institute for Cancer Research.

Top students admitted to the program will be designated I.J. Fidler Fellows in Metastasis Research. The awards honor Isaiah J. Fidler, D.V.M., Ph.D., director of M. D. Anderson's Cancer Metastasis Research Center and professor and former chair of the Department of Cancer Biology, a longstanding leader in research and translational programs in the area of metastasis whose pioneering work led to the recognition that metastasis is a separate discipline of cancer biology, providing the basis for this new program.
-end-
The GSBS is a combined program of M. D. Anderson and The University of Texas Health Science Center at Houston.

University of Texas M. D. Anderson Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.